| JMEA Current Events & Business Updates |
USPTO Grants JMEA Corporation a Patent for Devices and Methods for Preparation of Vertebral Members
Rockville, MD, March 28, 2019 (JMEA Corporation) – The United States Patent and Trademark Office (USPTO) issues JMEA Corporation a device and method patent for instruments for minimally invasive spine surgery to facilitate a faster and better discectomy process and prepare the endplates to receive an interbody fusion device. The JMEA RaptorTM Total Discectomy System (TDS) is an in situ expandable and adjustable tissue reamer instrument set and method to perform a rapid, precise discectomy through a minimally invasive incision and a very small annulotomy. To view this patent, please go to http://www.pat2pdf.org and search on 10238508, the patent number.
This patent brings JMEA’s patent portfolio to thirty-four (34) issued US patents and three (3) issued European patents. Currently, JMEA has patents issued in the spine, sports medicine, joint replacement and bone fixation technology areas. Our specific spine technologies include: Percutaneous/MIS Fusion, Dynamic Stabilization, Disc Annulus Repair, and Artificial Disc technology.
|
JMEA Corporation Granted 2 Additional Patents in 2018
Rockville, MD, September 5, 2018 (JMEA Corporation) – As of August 2018, the United States Patent and Trademark Office (USPTO) issued JMEA Corporation two (2) additional patents. In the first quarter of 2018, JMEA was granted a patent by the USPTO for our vertically expanding spinal interbody fusion technology – Vertically Expanding Crescent Cage (VECC). Like JMEA’s Fusion Coil System (FC360), the VECC can be delivered using an MIS technique via a TLIF (Transforaminal Lumbar Interbody Fusion) and then expanded vertically. To view this patent, please go to http://www.pat2pdf.org and search on 9901457, the patent number.
In the third quarter of 2018, the USPTO granted another patent to JMEA Corporation for its proprietary technology for a laterally or axially expanding minimally invasive interbody fusion device. This patent is part of JMEA’s patent family related to expandable interbody fusion devices. The JMEA Fusion Coil System (FC360) implant is a fusion device delivered using an MIS technique via a TLIF (Transforaminal Lumbar Interbody Fusion) or lateral approach. The JMEA FC360 offers a larger footprint with a smaller incision. To view this patent, please go to http://www.pat2pdf.org and search on 10039647, the patent number.
With these patents, JMEA’s patent portfolio grows to thirty-three (33) issued US patents and three (3) issued European patents. Currently, JMEA has patents issued in the spine, sports medicine, joint replacement and bone fixation technology areas. Our specific spine technologies include: Percutaneous/MIS Fusion, Dynamic Stabilization, Disc Annulus Repair, and Artificial Disc technology.
|
JMEA Corporation's Patent Portfolio Continues to Grow
ROCKVILLE, MD, March 20, 2017 (JMEA Corporation) -- JMEA’s patent portfolio grows to thirty one (31) issued US patents and three (3) issued European patents. Currently, JMEA has patents issued in the spine, sports medicine, joint replacement and bone fixation technology areas. Our specific spine technologies include: Percutaneous/MIS Fusion (spinal fusion performed through very small incisions), Dynamic Stabilization (spinal stabilization device that allows for motion at the same time), Disc Annulus Repair (repair of herniated spinal discs), and Artificial Disc technology (replacement of worn-out/damaged spinal discs and preserves motion).
JMEA Patents Issued through February 2017
United States Patents
European Patents
|
USPTO Issues JMEA Corporation a Patent for a Detachable Front Delivery Assembly for a Tissue Repair System
ROCKVILLE, MD, February 24, 2017 (JMEA Corporation) -- On February 21, 2017, JMEA Corporation was granted a patent by the United States Patent and Trademark Office (USPTO) for its proprietary technology for a Detachable Front Delivery Assembly for a Tissue Repair System. This patent application was originally filed on July 18, 2012 and is part of a set of patent applications filed related to JMEA’s proprietary technology to repair the rotator cuff.
With this patent, JMEA’s patent portfolio grows to thirty one (31) issued US patents and three (3) issued European patents. Currently, JMEA has patents issued in the spine, sports medicine, joint replacement and bone fixation technology areas. Our specific spine technologies include: Percutaneous/MIS Fusion, Dynamic Stabilization, Disc Annulus Repair, and Artificial Disc technology.
To view this patent, please go to http://www.pat2pdf.org and search on 9572615, the patent number.
|
USPTO Issues JMEA Corporation a Patent for a Dynamic Stabilization
Device for the Spine
ROCKVILLE, MD, December 22, 2011 (JMEA Corporation) -- On December 20, 2011,
JMEA Corporation was granted a patent by the United States Patent and Trademark
Office (USPTO) for its proprietary technology for a dynamic stabilization device for the
spine.
< Click the link to the right to READ THE ENTIRE ARTICLE >
| 
JMEA News Flash December 22, 2011 |
USPTO Issues JMEA Corporation a Fourth Patent for Disc Annulus Repair
ROCKVILLE, MD, December 16, 2011 (JMEA Corporation) -- On December 6, 2011,
JMEA Corporation was granted a fourth patent by the United States Patent and
Trademark Office (USPTO) for its proprietary technology to minimally invasively repair
the disc annulus and to repair other tissue.
< Click the link to the right to READ THE ENTIRE ARTICLE >
|
JMEA News Flash December 16, 2011 |
JMEA Passes FDA Inspection with Flying Colors
ROCKVILLE, MD, December 12, 2011 (JMEA Corporation) – JMEA Corporation was
issued a “Notice of Inspection” (FDA 482) on October 5, 2011. The inspection was
concluded on October 12, 2011. JMEA was found in compliance with the current
FDA Regulations. An FDA 483 (Inspectional Observations) was not issued. No
warnings or deficiencies were issued. On November 7, 2011 an Establishment Inspection Report (EIR) was issued confirming the results of the inspection.
< Click the link to the right to READ THE ENTIRE ARTICLE >
|
JMEA News Flash December 12, 2011 |
USPTO Issues JMEA Corporation a Patent for Disc Fusion and Artificial
Disc Replacement
ROCKVILLE, MD, April 15, 2011 (JMEA Corporation) -- On April 12, 2011, JMEA
Corporation was granted a patent by the United States Patent and Trademark Office
(USPTO) for its proprietary technology to minimally invasively perform a spinal fusion
or artificial disc replacement.
< Click the link to the right to READ THE ENTIRE ARTICLE >
|
JMEA News Flash April 15, 2011 |
Mr. Gregory Watko Joins JMEA Corporation as Director of Sales
ROCKVILLE, MD, February 8, 2011 (JMEA Corporation) -- JMEA Corporation is pleased to
announce that Gregory Watko has joined JMEA Corporation as Director of Sales. Mr. Watko has more than 25 years of experience in orthopedic sales and sales management. He has extensive sales management experience developing hybrid channels of distribution specializing in trauma, spine and sports medicine.
< Click the link to the right to READ THE ENTIRE ARTICLE >
|
JMEA News Flash February 08, 2011 |
| USPTO Issues JMEA Corporation a Third Patent for Disc Annulus Repair System
ROCKVILLE, MD, December 15, 2009 (JMEA Corporation) — On December 15, 2009, JMEA Corporation was granted a third patent by the United States Patent and Trademark Office (USPTO) ...
< Click the link to the right to READ THE ENTIRE ARTICLE >
|
JMEA New Flash: December 15,2009 |
USPTO Issues JMEA Corporation a Second Patent for Disc Annulus Repair System
ROCKVILLE, MD, November 24, 2009 (JMEA Corporation) — On October 27, 2009, JMEA Corporation was granted a patent by the United States Patent and Trademark Office (USPTO) ...
< Click the link to the right to READ THE ENTIRE ARTICLE >
|
JMEA New Flash: November 24,2009 |
USPTO Issues JMEA Corporation a Patent for Disc Annulus Repair System
ROCKVILLE, MD, June 22, 2009 (JMEA Corporation) — On June 16, 2009, JMEA Corporation was issued a patent by the United States Patent and Trademark Office (USPTO) ...
< Click the link to the right to READ THE ENTIRE ARTICLE >
|
JMEA News Flash: June 22, 2009 |
| FDA Clears JMEA Corporation’s Cannulated Bone Screw System for Knee Reconstruction
ROCKVILLE, MD, Sept. 16, 2008 (JMEA Corporation) — JMEA Corporation received clearance from the FDA to market its cannulated bone screw system for knee reconstruction ...
< Click the link to the right to READ THE ENTIRE ARTICLE >
|
JMEA New Flash: September 16,2008 |
|